Davidson Investment Advisors cut its position in shares of CVS Health Co. (NYSE:CVS – Free Report) by 26.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 161,371 shares of the pharmacy operator’s stock after selling 58,983 shares during the quarter. Davidson Investment Advisors’ holdings in CVS Health were worth $7,244,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently added to or reduced their stakes in the business. AMF Tjanstepension AB increased its stake in CVS Health by 124.1% in the third quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock valued at $3,882,000 after purchasing an additional 34,198 shares during the last quarter. Creative Planning lifted its position in CVS Health by 23.5% during the third quarter. Creative Planning now owns 250,891 shares of the pharmacy operator’s stock valued at $15,776,000 after buying an additional 47,737 shares in the last quarter. nVerses Capital LLC purchased a new position in CVS Health in the third quarter valued at about $101,000. Blue Trust Inc. grew its stake in shares of CVS Health by 6.2% in the third quarter. Blue Trust Inc. now owns 9,673 shares of the pharmacy operator’s stock valued at $571,000 after buying an additional 562 shares in the last quarter. Finally, Vest Financial LLC acquired a new stake in CVS Health during the 3rd quarter valued at $512,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on CVS shares. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price for the company in a research report on Tuesday, December 3rd. Piper Sandler lowered their price target on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a report on Monday, November 25th. Leerink Partnrs upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 12th. Royal Bank of Canada cut their price objective on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday, November 15th. Finally, Cantor Fitzgerald upgraded shares of CVS Health from a “neutral” rating to an “overweight” rating in a research report on Wednesday, February 12th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $70.28.
CVS Health Trading Down 1.0 %
CVS stock opened at $65.71 on Tuesday. The company has a market cap of $82.68 billion, a P/E ratio of 16.68, a PEG ratio of 0.60 and a beta of 0.61. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The business has a fifty day moving average of $51.11 and a 200-day moving average of $55.99.
CVS Health (NYSE:CVS – Get Free Report) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. As a group, equities research analysts expect that CVS Health Co. will post 5.14 EPS for the current year.
CVS Health Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.05%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is currently 67.51%.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Recommended Stories
- Five stocks we like better than CVS Health
- What is a buyback in stocks? A comprehensive guide for investors
- AMC Stock Surges on Bitcoin News—Meme Stocks Making a Comeback?
- What is Insider Trading? What You Can Learn from Insider Trading
- Hims & Hers: From Viral Ad to Volatile Stock
- How to trade using analyst ratings
- Beyond DeepSeek: 4 Chinese ETFs for AI & Tech Exposure
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.